- 英文名称
- (1R,2'R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,28S,29R)-22-Ethyl-7,11,14,15-tetrahydroxy-6'-((R)-2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-2,26-dioxaspiro[bicyclo[23.3.1]nonacosa[4,18,20]triene-27,2'-pyran]-3,9,13-trione
- 分子式
- C45H74O11
- 分子量
- 791.06
- 中文别名
- Oligomycin A; (1R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,27R,28S,29R)-22-ethyl-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonaMethyl-3',4',5',6'-tetrahydro-3H,9H,13H-spiro[2,26-dioxabicyclo[23.3.1]nonaco; (1R,4E,5'S,6S,6'S,7R,8S,10R,11R,12S,14R,15S,16R,18E,20E,22R,25S,27R,28S,29R)-22-ethyl-7,11,14,15-tetrahydroxy-6'-[(2R)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-3H,9H,13H-spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-pyran]-3,9,13-trione; Oligomycin A; (1S,4E,5'R,6R,6'R,7S,8R,10S,11S,12R,14S,15R,16S,18E,20E,22S,25R,27S,28R,29S)-22-Ethyl-7,11,14,15-tetrahydroxy-6'-[(2S)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-3H,9H,13H-spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-pyran]-3,9,13-trione; MCH 32; MFCD00065705; OLIGOMYCIN,STREPTOMYCES DIASTATOCHROMOGENES; EINECS 209-473-3; OLIGOMYCIN A,STREPTOMYCES DIASTATOCHROMOGENES
- 用途
- Oligomycin A是一种ATP synthase抑制剂，作用于线粒体膜的耦合过程，抑制氧化磷酸化和所有ATP依赖性反应；在体外研究中，100纳克/毫升的Oligomycin在1小时内完全抑制氧化磷酸化活性，6小时后引起不同程度的糖酵解，可抑制黑色素瘤中线粒体的呼吸作用，使黑色素瘤对治疗敏感，并阻断慢循环、长期肿瘤维持的黑色素瘤细胞的出现。
